Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
Pages
▼
Sunday, March 29, 2015
Brainstorm Cell Therapeutics Given "Buy" Rating at Maxim Group
's stock had its "buy" rating reissued by investment analysts at Maxim Group in a note issued to investors on Sunday. They currently have a $14.00 target price on the stock.
No comments:
Post a Comment